Eric Mcintyre News Today

/PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody...

Achieved total revenues of $38.1 million in the third quarter of 2023. Net product revenues for ZORYVE® cream 0.3% were $8.1 million, a 70% increase compared to the second quarter of 2023, driven by...

WESTLAKE VILLAGE, Calif., Oct. 19, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage company focused on developing meaningful innovations in immuno-dermatology, today announced the...

WESTLAKE VILLAGE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S.

The Artful Interior, Maine Art Gallery’s (MAG) final exhibit of 2023, and two years in the making, is every bit the standout season finale art enthusiasts want. An eclectic mix of wood, stone, clay, fiber, metal and canvas visually excites gallery-...

“To make something functional requires skill. To make something beautiful requires a refined aesthetic. To make something both functional and beautiful takes a very special kind of person,” says Cynthia Pappas, curator of the upcoming exhibition at...

Summer is the perfect time to escape the heat of Sarasota for Maine's crisp, cool nights.

Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

FinancialContent fully hosted finance channel

WESTLAKE VILLAGE, Calif., June 05, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in... | June 5, 2023